HemaSphere (Jun 2022)

P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT

  • J. M. Byun,
  • C.-K. Min,
  • K. Kim,
  • S.-M. Bang,
  • J.-J. Lee,
  • J. S. Kim,
  • S.-S. Yoon,
  • Y. Koh

DOI
https://doi.org/10.1097/01.HS9.0000846448.12828.50
Journal volume & issue
Vol. 6
pp. 785 – 786

Abstract

Read online

No abstracts available.